Literature DB >> 8652046

Protective immunity against HIV infection: has nature done the experiment for us?

G M Shearer1, M Clerici.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8652046     DOI： 10.1016/0167-5699(96)80564-0

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  36 in total

1.  Type 1 and type 2 cytokine gene expression by viral gp135 surface protein-activated T lymphocytes in caprine arthritis-encephalitis lentivirus infection.

Authors:  W P Cheevers; J C Beyer; D P Knowles
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection.

Authors:  M A Nowak; A L Lloyd; G M Vasquez; T A Wiltrout; L M Wahl; N Bischofberger; J Williams; A Kinter; A S Fauci; V M Hirsch; J D Lifson
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure.

Authors:  Silvana Tasca; Lily Tsai; Nataliya Trunova; Agegnehu Gettie; Mohammed Saifuddin; Rudolf Bohm; Lisa Chakrabarti; Cecilia Cheng-Mayer
Journal:  Virology       Date:  2007-06-15       Impact factor: 3.616

Review 4.  Guiding the vaginal microbicide trials with biomarkers of inflammation.

Authors:  Raina N Fichorova
Journal:  J Acquir Immune Defic Syndr       Date:  2004-10       Impact factor: 3.731

5.  Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus.

Authors:  D Pyeon; F J Diaz; G A Splitter
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

6.  beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques.

Authors:  J L Heeney; V J Teeuwsen; M van Gils; W M Bogers; C De Giuli Morghen; A Radaelli; S Barnett; B Morein; L Akerblom; Y Wang; T Lehner; D Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

7.  Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment.

Authors:  C C Tsai; P Emau; K E Follis; T W Beck; R E Benveniste; N Bischofberger; J D Lifson; W R Morton
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

8.  Th1/Th2 cytokine responses following HIV-1 immunization in seronegative volunteers. The AIDS Vaccine Evaluation Group.

Authors:  T G Evans; T Fitzgerald; D C Gibbons; M C Keefer; H Soucier
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

9.  Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals.

Authors:  Wildeman Zapata; Benigno Rodriguez; Jan Weber; Hernando Estrada; Miguel E Quiñones-Mateu; Peter A Zimermman; Michael M Lederman; Maria T Rugeles
Journal:  Curr HIV Res       Date:  2008-11       Impact factor: 1.581

10.  Persistently HIV-1 seronegative Nairobi sex workers are susceptible to in vitro infection.

Authors:  D Bienzle; K S Macdonald; K F Copeland; J J Bwayo; F A Plummer; K L Rosenthal
Journal:  Can J Infect Dis       Date:  2000-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.